Non-small-cell lung cancer (NSCLC) is a growing public-health threat, with one of the highest mortality risks among non-communicable diseases. Now, researchers have developed a diagnostic tool for NSCLC by mass spectrometry of a targeted panel of lipids. Herein, we discuss key aspects that could facilitate the clinical implementation of this and similar tools in other fields of application.

中文翻译：

---

丰富的循环脂质——NSCLC检测的新机遇？

非小细胞肺癌 (NSCLC) 是一种日益严重的公共卫生威胁，是非传染性疾病中死亡率最高的疾病之一。现在，研究人员已经开发出一种通过对靶向脂质组进行质谱分析的 NSCLC 诊断工具。在这里，我们讨论了可以促进该工具和类似工具在其他应用领域的临床实施的关键方面。